Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
暂无分享,去创建一个
M. Nucci | C. Robinson | S R Hamilton | M R Nucci | C R Robinson | P Longo | P Campbell | P. Longo | P. Campbell | S. Hamilton | P. Campbell
[1] P. J. Young,et al. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.
[2] A. Schauer,et al. Histochemical study of expression of lectin-reactive carbohydrate epitopes and glycoligand-binding sites in normal human appendix vermiformis, colonic mucosa, acute appendicitis and colonic adenoma. , 1996, Histology and histopathology.
[3] B. Trump,et al. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue. , 1985, Cancer Research.
[4] L. Roncucci,et al. K‐ras AND p53 MUTATIONS IN HUMAN COLORECTAL ABERRANT CRYPT FOCI , 1996, The Journal of pathology.
[5] F. dall’Olio,et al. Protein glycosylation in cancer biology: an overview , 1996, Clinical molecular pathology.
[6] M. Stolte,et al. Colorectal Mini-De Novo Carcinoma: A Reality in Germany Too , 1995, Endoscopy.
[7] M. Risio,et al. Mucosal cell proliferation in patients with hyperplastic colorectal polyps. , 1995, Scandinavian journal of gastroenterology.
[8] C. Boland,et al. Regional differences in normal and cancer-associated glycoconjugates of the human colon. , 1985, Journal of the National Cancer Institute.
[9] Christopher D. Heinen,et al. Microsatellite instability in aberrant crypt foci from human colons. , 1996, Cancer research.
[10] L. Roncucci,et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. , 1991, Human pathology.
[11] K. Forde,et al. Spatial clustering of multiple hyperplastic, adenomatous, and malignant colonic polyps in individual patients , 1989, Diseases of the colon and rectum.
[12] T. Muto,et al. Small “flat adenoma” of the large bowel with special reference to its clinicopathologic features , 1985, Diseases of the colon and rectum.
[13] M. Tsuneyoshi,et al. Depressed adenoma of the colorectum: Analysis of proliferative activity using immunohistochemical staining for proliferating cell nuclear antigen (PCNA) , 1994, Pathology international.
[14] M. Kaminishi,et al. Depressed adenoma in the large intestine , 1990, Diseases of the colon and rectum.
[15] R P Bird,et al. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.
[16] T. P. Pretlow,et al. Carcinoembryonic antigen in human colonic aberrant crypt foci. , 1994, Gastroenterology.
[17] S. Hamilton,et al. The adenoma‐adenocarcinoma sequence in the large bowel: Variations on a theme , 1992, Journal of cellular biochemistry. Supplement.
[18] K. Stȩpniewska,et al. High frequency of K-ras mutations in sporadic colorectal adenomas. , 1993, Gut.
[19] K. Kinzler,et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.
[20] M. Ilyas,et al. Genetic pathways in colorectal cancer , 1996, Histopathology.
[21] J. C. Lee,et al. Growth kinetics of colorectal adenoma-carcinoma sequence: an immunohistochemical study of proliferating cell nuclear antigen expression. , 1996, Human pathology.
[22] A. Kinsella,et al. K-ras gene mutations in adenomas and carcinomas of the colon. , 1992, Surgical oncology.
[23] M. Fukayama,et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. , 1994, Cancer research.
[24] I. Siu,et al. Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. , 1996, Gastroenterology.
[25] S. Hamilton. Pathogenesis of polyps (adenomas) , 1983, Diseases of the colon and rectum.
[26] E. Kaplan,et al. K-ras mutations in putative preneoplastic lesions in human colon. , 1993, Journal of the National Cancer Institute.
[27] H. Esumi,et al. Frequent and characteristic K‐ras activation in aberrant crypt foci of colon. Is there preference among K‐ras mutants for malignant progression? , 1995, Cancer.
[28] H. Bussey,et al. Familial polyposis coli. , 1975, Pathology annual.
[29] S. Gallinger,et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. , 1994, Cancer research.
[30] E. Wiley,et al. Distribution of blood group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technic to identify A and B blood group substances. , 1981, American journal of clinical pathology.
[31] D. Owen,et al. Flat adenomas of the colon. , 1991, Human pathology.
[32] E. Riecken,et al. Alteration of mucin-bound carbohydrate moieties in malignant transformation of colonic mucosa , 1992 .
[33] E. Campo,et al. Lectin binding patterns in normal and neoplastic colonic mucosa , 1988, Diseases of the colon and rectum.
[34] U Landegren,et al. A ligase-mediated gene detection technique. , 1988, Science.
[35] G. Yang,et al. Gal-GalNAc: a biomarker of colon carcinogenesis. , 1996, Histology and histopathology.
[36] T. Muto,et al. Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas , 1994, Japanese journal of cancer research : Gann.
[37] M. Fukuda. Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.
[38] T. P. Pretlow,et al. Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. , 1993, The American journal of pathology.
[39] K. Kinzler,et al. Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.
[40] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[41] P. Quirke,et al. p53 expression and K-ras mutation in colorectal adenomas. , 1993, Gut.
[42] H. Esumi,et al. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. , 1995, Gastroenterology.
[43] B. Trump,et al. Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. , 1981, Journal of the National Cancer Institute.
[44] E. Deschner. Experimentally induced cancer of the colon , 1974, Cancer.
[45] N. Marcon,et al. Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. , 1984, The American journal of surgical pathology.
[46] H. Cooper,et al. Peanut lectin binding sites in colons of patients with ulcerative colitis. , 1987, Archives of pathology & laboratory medicine.
[47] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[48] C. Moskaluk,et al. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. , 1997, The American journal of pathology.
[49] M. Herlyn,et al. Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[50] R Levine,et al. Prevention and early detection of colorectal cancer. , 1992, American family physician.
[51] A. Yanagisawa,et al. Variation in K‐ras Codon 12 Point Mutation Rate with Histological Atypia within Individual Colorectal Tumors , 1993, Japanese journal of cancer research : Gann.
[52] S. Kudo,et al. The problem of de novo colorectal carcinoma. , 1995, European journal of cancer.
[53] A. E. Szulman. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE , 1962, The Journal of experimental medicine.
[54] L. Sobin,et al. Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine. , 1995, Journal of clinical pathology.
[55] Fairman Mp. DNA polymerase delta/PCNA: actions and interactions. , 1990 .
[56] L. Roncucci,et al. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). , 1993, Cancer research.
[57] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[58] H. Cooper,et al. Hyperplastic polyps of the colon and rectum. An immunohistochemical study with monoclonal antibodies against blood groups antigens (sialosyl-Lea, Leb, Lex, Ley, A, B, H). , 1987, Laboratory investigation; a journal of technical methods and pathology.
[59] T. Sugimura,et al. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. , 1994, Cancer research.
[60] A. Shamsuddin,et al. Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa. , 1987, Human pathology.
[61] G. Corner,et al. Evidence for genomic instability in human colonic aberrant crypt foci. , 1996, Oncogene.
[62] Masaki Kitajima,et al. Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma , 1995 .
[63] P. Hall,et al. The complexities of proliferating cell nuclear antigen , 1992, Histopathology.
[64] K. Kinzler,et al. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. , 1996, The American journal of pathology.
[65] K. Tanaka,et al. Familial polyposis: recent advances. , 1995, Critical reviews in oncology/hematology.
[66] C. Fenoglio-Preiser,et al. Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.
[67] M. Kobayashi,et al. Effect of K-ras mutation on morphogenesis of colorectal adenomas and early cancers: relationship to distribution of proliferating cells. , 1996, Human pathology.
[68] Bert Vogelstein,et al. APC mutations occur early during colorectal tumorigenesis , 1992, Nature.
[69] John I. Allen,et al. Molecular biology of colon polyps and colon cancer. , 1995, Seminars in surgical oncology.
[70] H. Esumi,et al. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. , 1995, Cancer research.
[71] V. Reuter,et al. Peanut lectin-binding sites in polyps of the colon and rectum. Adenomas, hyperplastic polyps, and adenomas with in situ carcinoma. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[72] R P Bird,et al. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 1995, Cancer letters.
[73] A. E. Szulman. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE , 1964, The Journal of experimental medicine.
[74] M. Melamed,et al. Immunohistologic expression of blood‐group antigens in normal human gastrointestinal tract and colonic carcinoma , 1986, International journal of cancer.
[75] J. Jass. RELATION BETWEEN METAPLASTIC POLYP AND CARCINOMA OF THE COLORECTUM , 1983, The Lancet.
[76] I. Kino,et al. Depressed adenomas of the colon in familial adenomatous polyposis. Histology, immunohistochemical detection of proliferating cell nuclear antigen (PCNA), and analysis of the background mucosa. , 1995, American Journal of Surgical Pathology.
[77] J. Jass,et al. Sialic Acid and Epithelial Differentiation in Colorectal Polyps and Cancer – A Morphological, Mucin and Lectin Histochemical Study , 1992, Pathology.
[78] C. Boland,et al. Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium , 1992, Journal of cellular biochemistry. Supplement.